PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome. [PDF]
Beck DB +14 more
europepmc +1 more source
Case Report: Early-onset VEXAS syndrome with recurrent pulmonary inflammation and myelodysplasia: a diagnostic and therapeutic challenge. [PDF]
Jin X +6 more
europepmc +1 more source
Clinical, laboratory and genetic characteristics of VEXAS syndrome: a study on behalf of GESMD. [PDF]
Fonseca-Santos M +27 more
europepmc +1 more source
Expanding the Clinical Spectrum of VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome: The First Report of Histologically Confirmed Neutrophilic Colitis With Rare Muscular and Pancreatic Involvement. [PDF]
El Tahech S +3 more
europepmc +1 more source
VEXAS Syndrome: An Overlooked Threat
Ugurlu, Serdal, Kilic, Berkay
openaire +4 more sources
A Case of VEXAS Syndrome Initially Masked as Myelodysplastic Syndrome: Importance of Marrow Vacuolization and UBA1 Testing: A Case Report. [PDF]
Shahverdi E +6 more
europepmc +1 more source
Large-Vessel Vasculitis With Autoimmune Myelodysplastic Syndrome: An Uncommon Case of Large-Vessel Vasculitis With Cytopenia That Is Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic Syndrome (VEXAS) Negative. [PDF]
George P S B +4 more
europepmc +1 more source
Hemi-Orolingual Angioedema in a Patient With VEXAS Syndrome. [PDF]
Suárez EU +2 more
europepmc +1 more source
Rapid cutaneous remission response to tofacitinib and systemic corticosteroids in VEXAS syndrome with a novel UBA1 mutation. [PDF]
Wang Z, Shi H, Jiang Y.
europepmc +1 more source

